Biopol Chemicals IPO Details
| Detail | Description |
|---|---|
| IPO Date | 6 to 10 Feb, 2026 |
| Listing Date | Fri, Feb 13, 2026 |
| Face Value | ₹ 10 per share |
| Issue Price Band | ₹ 102 to ₹ 108 |
| Lot Size | 1,200 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 28,94,400 shares (agg. up to ₹ 31 Cr) |
| Reserved for Market Maker | 1,51,200 shares (agg. up to ₹ 2 Cr) Shreni Shares Ltd. |
| Net Offered to Public | 27,43,200 shares (agg. up to ₹ 30 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 79,11,000 shares |
| Share Holding Post Issue | 1,08,05,400 shares |
About Biopol Chemicals IPO
Biopol Chemical IPO is a book-building issue of ₹31.26 crore, 100% of the fresh issue of 0.29 crore shares. The price band is set at ₹102 to ₹108 per share and the lot size for an application is 1,200. The minimum amount required by an individual investor is ₹2,59,200 (2,400 shares). The IPO opens for subscription from February 6, 2026, to February 11, 2026, on the NSE SME platform with a tentative listing date fixed as Feb 13, 2026.
Company Background
Biopol Chemical Ltd. was incorporated in 2023, based in Kolkata, but its registered office is in Gujarat. This is a research-focused and technology-strong company that is engaged in the manufacturing and distribution of specialty chemicals. They have a portfolio that comprises 66 products, which include 40 silicone, 5 emulsifiers, 15 biochemical and 6 polyelectrolyte products. The manufacturing unit has an installed capacity of 18,25,000 liters per annum of the products.
Operations and Product Range
Facility and Production
Biopol Chemicals Ltd. operates a manufacturing unit in West Bengal with an installed capacity of 18,25,000 litres per annum. The company also has a corporate office and warehouse in West Bengal, and a registered office in Gujarat. The company is planning an expansion to acquire land in Gujarat for an additional manufacturing unit. The production units are described as state-of-the-art.
Brands and Market Presence
The company manufactures 66 specialty chemical products, including silicones, emulsifiers, biochemicals, and polyelectrolytes, which are ZDHC Level 3.0 certified. These products serve industries such as textiles, home care, agriculture, and industrial chemicals. Biopol has a strategic presence in Gujarat and West Bengal and export operations in Bangladesh.
Revenue Channels
- • Manufacturing and distribution of 66 chemical products
- • Market presence in high-demand industrial hubs (i.e, West Bengal and Gujarat)
- • Export of products to Bangladesh
- • Sales of textile chemicals, home care, agriculture and industrial chemicals
Management and Shareholding
Promoters and Shareholding
Mr. Santanu Sarkar (Chairman & Managing Director) and Mr. Vedant Sarkar (Whole Time Director) are the key promoters of the company. Before the Biopol Chemical IPO, the promoters held a majority stake, but after the IPO, their shareholding is expected to dilute as Offer for Sale (OFS) shares are offered in the upcoming Biopol Chemical IPO.
Board Members
The board members of Biopol Chemical Ltd. include Mr. Santanu Sarkar (Chairman & Managing Director) and Mr. Vedant Sarkar (Whole Time Director). Non-Executive Independent Directors are Ms. Preety Priya Ghosh, Mr. Gaurav Mittal, and Mr. Kaushikkumar Vasantbhai Darji. Other key personnel include Ms. Deepti Nama (CS) and Mr. Sandip Choudhury (CFO).
Biopol Chemical IPO Objectives
- • Acquisition of industrial land
- • Repayment of debt to strengthen the balance sheet
- • General corporate purposes
Conclusion
Biopol Chemical IPO provides an opportunity to invest in a growing company that is in the manufacturing and distribution of specialty chemicals, with its key registered office in Gujarat and West Bengal, the main regional high-demand areas. The IPO proceeds are planned to be used in the acquisition of the industrial land, repayment of debt (pre-payment or full-payment). The consistent growth and revenue generation of Biopol Chemical Ltd. made investors more interested in the IPO.
Biopol Chemicals IPO Financial Information
Latest Revenue
48.97
₹ Crore
Profit After Tax
6.00
₹ Crore
Net Worth
19.54
₹ Crore
Total Borrowing
14.92
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Reserves & Surplus | Total Borrowing | |||
|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 2025 | 48.88 | 48.97 | 6.00 | 19.54 | 11.63 | 14.92 | |||
| 31 Mar 2025 | 31.48 | 49.15 | 4.33 | 13.53 | 5.62 | 7.69 | |||
| 31 Mar 2024 | 17.56 | 17.43 | 2.96 | 9.20 | 1.29 | 3.58 | |||
| Amount in ₹ Crore | |||||||||
Biopol Chemicals Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 38.10% |
| ROCE | 30.57% |
| Debt/Equity | 0.57 |
| RoNW | 32.00% |
| PAT Margin | 8.81% |
| EBITDA Margin | 13.30% |
| Price to Book Value | 6.31 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 5.47 | 7.41 |
| P/E (x) | 19.73 | 14.58 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Manufacturing unit and order book
Quality standard certification
Strategic presence in the top manufacturing cities like Gujarat and West Bengal
Export operations in Bangladesh
Download regulatory filings
Biopol Chemicals IPO Timeline
| IPO Open Date | Fri, Feb 6, 2026 |
| IPO Close Date | Tue, Feb 10, 2026 |
| Tentative Allotment | Wed, Feb 11, 2026 |
| Initiation of Refunds | Thu, Feb 12, 2026 |
| Credit of Shares to Demat | Thu, Feb 12, 2026 |
| Tentative Listing Date | Fri, Feb 13, 2026 |
| Cut-off time for UPI mandate confirmation | - |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2,400 | ₹2,59,200 |
| Individual investors (Retail) (Max) | 2 | 2,400 | ₹2,59,200 |
| S-HNI (Min) | 3 | 3,600 | ₹3,88,800 |
| S-HNI (Max) | 7 | 8,400 | ₹9,07,200 |
| B-HNI (Min) | 8 | 9,600 | ₹10,36,800 |


